Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer.
about
Redox regulation of T-cell function: from molecular mechanisms to significance in human health and diseaseImmunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancerTumor infiltrating lymphocytes in ovarian cancerAn immunologic portrait of cancerTargeted immune therapy of ovarian cancerEpithelial ovarian cancer - more data, more questions?Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer.Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factorsEndothelin B receptor, a new target in cancer immune therapy.The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis.BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosisImmunotherapy for ovarian cancer: what's next?Immune cells in the normal ovary and spontaneous ovarian tumors in the laying hen (Gallus domesticus) model of human ovarian cancerThe emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decade.Whole tumor antigen vaccines.Tissue-based immune monitoring I: tumor core needle biopsies allow in-depth interrogation of the tumor microenvironment.Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma.Preservation of tumor-host immune interactions with luciferase-tagged imaging in a murine model of ovarian cancerPrognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis.Profiling the immune stromal interface in breast cancer and its potential for clinical impactIntraepithelial T cells and tumor-associated macrophages in ovarian cancer patients.A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer.Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancer.Differential distribution of tumor-associated macrophages and Treg/Th17 cells in the progression of malignant and benign epithelial ovarian tumors.The immune system in the pathogenesis of ovarian cancer.Tumor-Associated Macrophages and Myeloid-Derived Suppressor Cells as Immunosuppressive Mechanism in Ovarian Cancer Patients: Progress and Challenges.Prediction of therapy response in ovarian cancer: Where are we now?Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancerAssessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract CaCirculating cell-free DNA and circulating tumor cells, the "liquid biopsies" in ovarian cancer.Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission.Immune Infiltration in Invasive Lobular Breast Cancer.
P2860
Q26824042-B7236F22-2D41-4EB7-BB97-CE6D06E56DC9Q26996829-98D148BB-ABF5-440A-9384-3B4E9FC0A567Q27021878-E5E16674-F028-4282-9E48-4BAD8D889917Q27028000-9723750A-86A7-48B9-92DA-FBCE782950C5Q28082828-78A8770E-7145-45A2-B25C-A7D953F03AD8Q30869183-E0F5A94F-39EC-49DB-B9A1-E19255AD9403Q33377058-06EBDFF5-1A3A-423C-B41B-FFB679D760D9Q33488520-8EA00C0D-EA6E-499F-BABD-A46BC6003628Q33960710-FD696EB5-1840-449B-A3FE-E7C438D26FABQ34188723-8BC8ED6C-C62D-4165-AA62-C026D28C2A21Q34299655-BA29FEDE-F52E-4B41-9441-85AB99321BB3Q34743514-A37F3538-64F7-48E3-8E3D-6119192C5257Q34989820-770900DC-298E-4D0A-887B-90A36E1F7C5DQ35058213-692220EE-11B6-499A-BAB4-3C85447A99A3Q35058235-FFBC1D5E-3450-4093-8F75-56A48712D877Q35214729-048A9DD9-A3D1-452A-991B-EFF2C820E78AQ35214732-FDBBB44B-ECE6-4E81-BF3E-2ABBD6733716Q35623804-0577157C-EB5A-417E-83F8-459C5A975FCEQ35818203-47F3ADD6-0814-4E70-A09B-C49DDE38509FQ36449295-08C0B277-B506-433A-8E35-04CDB81D9183Q36574427-DF24541B-2650-4956-A0A5-C12A685F0BBCQ36958112-46769E99-E963-477E-940B-A89848A6623CQ37369523-36BDB411-2AD1-4938-AC8F-E5F94C801627Q37594103-B382117B-D6B2-4D9E-A17E-6451D072EC10Q37613407-0C20EED5-EAE1-48A6-981C-206B2F84E6D6Q38958680-F3C6CB04-DC62-4C38-A0AB-4BB504D9D6F2Q39263260-3E3CD448-3657-443E-AA8A-46B5DC254F4FQ41695706-E29A6EA9-BB56-4758-A97A-B9749FB6BBF6Q46540302-1AFF5E32-9E02-471D-B5DB-282DCA7253C3Q47094357-296B177F-70DC-4DA0-9C9E-E8AB951CD93EQ47993135-9333EF7E-7EA0-4702-A21D-D1280538A4E1Q50145963-F3AFF017-208E-4E2F-91A6-9BC4F9977FD2
P2860
Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Intratumoral T cells, tumor-as ...... in women with ovarian cancer.
@en
Intratumoral T cells, tumor-as ...... in women with ovarian cancer.
@nl
type
label
Intratumoral T cells, tumor-as ...... in women with ovarian cancer.
@en
Intratumoral T cells, tumor-as ...... in women with ovarian cancer.
@nl
prefLabel
Intratumoral T cells, tumor-as ...... in women with ovarian cancer.
@en
Intratumoral T cells, tumor-as ...... in women with ovarian cancer.
@nl
P2093
P1433
P1476
Intratumoral T cells, tumor-as ...... l in women with ovarian cancer
@en
P2093
Elizabeth M Swisher
Heidi J Gray
Kimberly H Allison
Rochelle L Garcia
P304
P356
10.1016/J.YGYNO.2008.01.010
P407
P577
2008-03-07T00:00:00Z